Overview

Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas

Status:
Completed
Trial end date:
2020-11-18
Target enrollment:
Participant gender:
Summary
This is a phase II study of metronomic chemotherapy in elderly non-fit patients (>65 years) with aggressive B-Cell lymphomas
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Linfomi ONLUS
Treatments:
Cyclophosphamide
Etoposide
Etoposide phosphate
Prednisone
Rituximab
Vinblastine
Vinorelbine